ICeram Financial Statements From 2010 to 2024

ALICR Stock  EUR 0.40  0.06  13.04%   
ICeram SA financial statements provide useful quarterly and yearly information to potential ICeram SA investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on ICeram SA financial statements helps investors assess ICeram SA's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting ICeram SA's valuation are summarized below:
ICeram SA does not currently have any fundamental trends for analysis.
Check ICeram SA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ICeram SA's main balance sheet or income statement drivers, such as , as well as many indicators such as . ICeram financial statements analysis is a perfect complement when working with ICeram SA Valuation or Volatility modules.
  
This module can also supplement various ICeram SA Technical models . Check out the analysis of ICeram SA Correlation against competitors.

ICeram SA Company Current Valuation Analysis

ICeram SA's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current ICeram SA Current Valuation

    
  5.03 M  
Most of ICeram SA's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ICeram SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, ICeram SA has a Current Valuation of 5.03 M. This is 99.96% lower than that of the Health Care Equipment & Supplies sector and 99.94% lower than that of the Health Care industry. The current valuation for all France stocks is 99.97% higher than that of the company.

ICeram SA Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ICeram SA's current stock value. Our valuation model uses many indicators to compare ICeram SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ICeram SA competition to find correlations between indicators driving ICeram SA's intrinsic value. More Info.
ICeram SA is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ICeram SA's earnings, one of the primary drivers of an investment's value.

About ICeram SA Financial Statements

ICeram SA shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although ICeram SA investors may analyze each financial statement separately, they are all interrelated. The changes in ICeram SA's assets and liabilities, for example, are also reflected in the revenues and expenses on on ICeram SA's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
I.CERAM SA designs, manufactures, and markets alumina bio-ceramic implants in France and internationally. The company was founded in 2005 and is based in Limoges, France. I CERAM operates under Medical Instruments Supplies classification in France and is traded on Paris Stock Exchange. It employs 44 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for ICeram Stock Analysis

When running ICeram SA's price analysis, check to measure ICeram SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICeram SA is operating at the current time. Most of ICeram SA's value examination focuses on studying past and present price action to predict the probability of ICeram SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICeram SA's price. Additionally, you may evaluate how the addition of ICeram SA to your portfolios can decrease your overall portfolio volatility.